Pharmacogenomics as a Tool to Limit Acute and Long-Term Adverse Effects of Chemotherapeutics: An Update in Pediatric Oncology
In the past decades, new cancer treatments have been introduced in pediatric oncology leading to improvement in clinical outcomes and survival rates. However, due to inter-individual differences, some children experience severe chemotherapy-induced toxicities or a poor clinical outcome. An explanati...
Saved in:
Main Authors: | Emma C. Bernsen (Author), Melanie M. Hagleitner (Author), Theodorus W. Kouwenberg (Author), Lidwien M. Hanff (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Extracellular Vesicles: A Novel Tool Facilitating Personalized Medicine and Pharmacogenomics in Oncology
by: Katja Goričar, et al.
Published: (2021) -
Practical Recommendations for the Manipulation of Kinase Inhibitor Formulations to Age-Appropriate Dosage Forms
by: Emma C. Bernsen, et al.
Published: (2022) -
ADVERSE EFFECTS IN THE ORO-MAXILLO-FACIAL TERITORY CAUSED BY CHEMOTHERAPEUTICS USED IN THE TREATMENT OF ONCOLOGICAL PATIENTS. REVIEW
by: Diana-Cristala Kapp, et al.
Published: (2019) -
Update on the pharmacogenomics of pain management
by: Kaye AD, et al.
Published: (2019) -
Pigmentary adverse effects of chemotherapeutic agents
by: Neerja Saraswat, et al.
Published: (2019)